RemeGen Co., Ltd. Share Price
Stocks
9995
CNE1000048G6
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 68.40 HKD | -5.20% |
|
-1.23% | -5.00% |
| Market Cap | 50.26B 58.24B 7.43B 6.41B 5.9B 5.54B 10.4B 703B 10.51B 69.72B 27.16B 344B 27.9B 27.31B 1,193B | P/E Ratio 2026 * |
10.1x | P/E Ratio 2027 * | 41.8x |
|---|---|---|---|---|---|
| Enterprise Value | 46.78B 54.21B 6.92B 5.96B 5.49B 5.16B 9.68B 654B 9.78B 64.89B 25.28B 320B 25.97B 25.42B 1,110B | EV / Sales 2026 * |
6.66x | EV / Sales 2027 * | 9.58x |
| Free-Float |
62.74% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -5.20% | ||
| 1 week | -1.23% | ||
| Current month | -17.24% | ||
| 1 month | -23.45% | ||
| 3 months | -24.50% | ||
| 6 months | -10.35% | ||
| Current year | -5.00% |
| 1 week | 66.75 | 76.4 | |
| 1 month | 66 | 90.7 | |
| Current year | 66 | 123.1 | |
| 1 year | 48.55 | 126.6 | |
| 3 years | 10.2 | 126.6 | |
| 5 years | 10.2 | 145.5 | |
| 10 years | 10.2 | 149.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Min Fang
CEO | Chief Executive Officer | 64 | 03/07/2008 |
Shao Jing Tong
DFI | Director of Finance/CFO | 55 | 27/09/2023 |
Qing Kai Wen
SEC | Corporate Secretary | 60 | 10/05/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Jian Min Fang
BRD | Director/Board Member | 64 | 03/07/2008 |
Jian Lin
BRD | Director/Board Member | 71 | 03/07/2008 |
Liqiang Wang
BRD | Director/Board Member | 56 | 10/05/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03-31 | Other | Founder | 70,000 | 0.0336% | ||
| 03-31 | Other | Director | 2,970 | 0.0014% | ||
| 03-31 | Other | Director | 23,630 | 0.0113% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.20% | -1.23% | +26.20% | +85.87% | 7.77B | ||
| -0.71% | -0.29% | +56.45% | +107.18% | 54.92B | ||
| -1.22% | +2.25% | +43.78% | +38.45% | 44.31B | ||
| -1.43% | +3.47% | -15.83% | -20.48% | 22.96B | ||
| -1.99% | -3.55% | -5.97% | +377.60% | 21.12B | ||
| -2.91% | +0.27% | +13.28% | -36.73% | 16.31B | ||
| -2.38% | -3.38% | +5.53% | -41.88% | 15.19B | ||
| -1.70% | -1.68% | +24.79% | +172.92% | 13.32B | ||
| +1.48% | +9.81% | +19.29% | - | 12.48B | ||
| +4.10% | +0.10% | +108.68% | +226.33% | 11.21B | ||
| Average | -1.20% | +1.78% | +27.62% | +101.03% | 21.96B | |
| Weighted average by Cap. | -1.14% | +1.18% | +31.17% | +93.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.03B 8.14B 1.04B 896M 825M 774M 1.45B 98.26B 1.47B 9.75B 3.8B 48.12B 3.9B 3.82B 167B | 4.73B 5.49B 700M 603M 556M 522M 979M 66.2B 990M 6.57B 2.56B 32.42B 2.63B 2.57B 112B |
| Net income | 3.54B 4.11B 524M 452M 416M 390M 733M 49.55B 741M 4.91B 1.91B 24.26B 1.97B 1.92B 84.08B | 853M 988M 126M 109M 100M 94M 176M 11.93B 178M 1.18B 461M 5.84B 473M 463M 20.24B |
| Net Debt | -3.48B -4.03B -515M -444M -408M -383M -720M -48.66B -728M -4.83B -1.88B -23.83B -1.93B -1.89B -82.58B | -4.9B -5.67B -724M -624M -575M -540M -1.01B -68.47B -1.02B -6.79B -2.65B -33.53B -2.72B -2.66B -116B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/06/26 | 68.40 $ | -5.20% | 3,257,240 |
| 15/06/26 | 72.15 $ | -3.22% | 3,655,100 |
| 12/06/26 | 74.55 $ | +7.04% | 7,815,688 |
| 11/06/26 | 69.65 $ | -0.50% | 3,155,073 |
| 10/06/26 | 70.00 $ | +1.08% | 4,094,540 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 9995 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















